• Log In
  • Register
  • Home
  • About NMSG
  • Membership
  • Clinical Trials
  • Fellowship
  • Publications
  • Resources
    • Resources
    • Upcoming Neuromuscular Meetings
  • NMSG Meetings
    • 2022 Neuromuscular Study Group Annual Scientific Meeting
    • MSG Shark Tank 2022
    • 2023 Neuromuscular Study Group Annual Scientific Meeting
    • Meetings Archive
Skip to content

Neuromuscular Study Group

  • Log In
  • Register
  • Home
  • About NMSG
  • Membership
  • Clinical Trials
  • Fellowship
  • Publications
  • Resources
    • Resources
    • Upcoming Neuromuscular Meetings
  • NMSG Meetings
    • 2022 Neuromuscular Study Group Annual Scientific Meeting
    • MSG Shark Tank 2022
    • 2023 Neuromuscular Study Group Annual Scientific Meeting
    • Meetings Archive
msg-admin

Phase 2 Study of Rasagiline for Treatment of Amyotrophic Lateral Sclerosis (Rasagiline)

Posted on April 7, 2016 by msg-admin

Link: https://clinicaltrials.gov/ct2/show/NCT01786603
Year Trial Ends: 2021
This entry was posted in Completed. Bookmark the permalink.

Contact Us

Elizabeth Russo Paulk
Neuromuscular Study Group

Privacy Policy

Site Search

Join the Neuromuscular Study Group

© The Neuromuscular Study Group Inc. All rights reserved. Site by Academic Web Pages

Back to Top